Literature DB >> 30040967

Mycobacterium marinum infection drives foam cell differentiation in zebrafish infection models.

Matt D Johansen1, Joshua A Kasparian1, Elinor Hortle2, Warwick J Britton3, Auriol C Purdie4, Stefan H Oehlers5.   

Abstract

Host lipid metabolism is an important target for subversion by pathogenic mycobacteria such as Mycobacterium tuberculosis. The appearance of foam cells within the granuloma are well-characterised effects of chronic tuberculosis. The zebrafish-Mycobacterium marinum infection model recapitulates many aspects of human-M. tuberculosis infection and is used as a model to investigate the structural components of the mycobacterial granuloma. Here, we demonstrate that the zebrafish-M. marinum granuloma contains foam cells and that the transdifferentiation of macrophages into foam cells is driven by the mycobacterial ESX1 pathogenicity locus. This report demonstrates conservation of an important aspect of mycobacterial infection across species.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Foam cell; Granuloma; Lipid; Mycobacterium; Pathogenesis; Zebrafish

Mesh:

Substances:

Year:  2018        PMID: 30040967     DOI: 10.1016/j.dci.2018.07.022

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  10 in total

Review 1.  Foam Cells: One Size Doesn't Fit All.

Authors:  Valentina Guerrini; Maria Laura Gennaro
Journal:  Trends Immunol       Date:  2019-11-12       Impact factor: 16.687

2.  Thrombocyte Inhibition Restores Protective Immunity to Mycobacterial Infection in Zebrafish.

Authors:  Elinor Hortle; Khelsey E Johnson; Matt D Johansen; Tuong Nguyen; Jordan A Shavit; Warwick J Britton; David M Tobin; Stefan H Oehlers
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

3.  OXSR1 inhibits inflammasome activation by limiting potassium efflux during mycobacterial infection.

Authors:  Elinor Hortle; Vi Lt Tran; Kathryn Wright; Angela Rm Fontaine; Natalia Pinello; Matthew B O'Rourke; Justin J-L Wong; Philip M Hansbro; Warwick J Britton; Stefan H Oehlers
Journal:  Life Sci Alliance       Date:  2022-05-11

Review 4.  Zebrafish as a Model for Fish Diseases in Aquaculture.

Authors:  Louise von Gersdorff Jørgensen
Journal:  Pathogens       Date:  2020-07-27

Review 5.  One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics.

Authors:  Hee-Jeong Yang; Decheng Wang; Xin Wen; Danielle M Weiner; Laura E Via
Journal:  Front Cell Infect Microbiol       Date:  2021-03-16       Impact factor: 5.293

6.  The zebrafish embryo as an in vivo model for screening nanoparticle-formulated lipophilic anti-tuberculosis compounds.

Authors:  Nils-Jørgen Knudsen Dal; Martin Speth; Kerstin Johann; Matthias Barz; Claire Beauvineau; Jens Wohlmann; Federico Fenaroli; Brigitte Gicquel; Gareth Griffiths; Noelia Alonso-Rodriguez
Journal:  Dis Model Mech       Date:  2022-01-26       Impact factor: 5.758

Review 7.  Progress of the Art of Macrophage Polarization and Different Subtypes in Mycobacterial Infection.

Authors:  Gai Ge; Haiqin Jiang; Jingshu Xiong; Wenyue Zhang; Ying Shi; Chenyue Tao; Hongsheng Wang
Journal:  Front Immunol       Date:  2021-11-09       Impact factor: 7.561

Review 8.  Application of zebrafish in the study of the gut microbiome.

Authors:  Xiaoting Zhong; Jinglin Li; Furong Lu; Jingjing Zhang; Lianxian Guo
Journal:  Animal Model Exp Med       Date:  2022-04-12

Review 9.  A fresh look at mycobacterial pathogenicity with the zebrafish host model.

Authors:  Monica Varela; Annemarie H Meijer
Journal:  Mol Microbiol       Date:  2021-11-07       Impact factor: 3.979

10.  Glucose inhibits haemostasis and accelerates diet-induced hyperlipidaemia in zebrafish larvae.

Authors:  Simone Morris; Pradeep Manuneedhi Cholan; Warwick J Britton; Stefan H Oehlers
Journal:  Sci Rep       Date:  2021-09-24       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.